Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesBarclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Hut 8's stock surged on news of a landmark AI data center deal valued at $9.8 billion, positioning the crypto miner t...
Real-world assets are flowing into on-chain markets as AI-enabled DeFi trading grows. Galaxy Digital and Ondo report ...
C3.AI has faced a rough run, leaving investors wondering if a comeback is possible. This article breaks down the fact...
NVIDIA will begin counting stock-based compensation in non-GAAP results from Q1 FY2027, a shift that rekindles a long...
A federal probe into Tesla's FSD system raises questions for investors about safety, costs, and stock risk. This guid...
Palantir’s latest quarter delivered impressive numbers, but the stock asks for more than strong growth. This guide br...
A newly launched AI agent is set to overhaul how builders screen land and gauge deal risk, potentially speeding loans...
A new wave of pre-IPO trading is reshaping access to private company bets. This guide breaks down why traders are flo...
A Supreme Court ruling curbs the president’s tariff powers under IEEPA, easing uncertainty for manufacturers. A CFO w...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
ECL, EMN, and BCC report mixed quarters as 2026 guidance and cost actions set the tone for a volatile chemicals secto...